Cargando…
Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
Use of intrathecal gadolinium for contrast-enhanced myelography and cisternography remains off-label and is currently not FDA-approved. We report a 70-year-old male who underwent CT myelogram utilizing off-label high-dose intrathecal gadolinium who developed altered mental status and bilateral heari...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452073/ https://www.ncbi.nlm.nih.gov/pubmed/32874398 http://dx.doi.org/10.1016/j.radcr.2020.07.084 |